LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding.

    Purushotham, Aparna / Xu, Qing / Li, Xiaoling

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2011  Volume 26, Issue 2, Page(s) 656–667

    Abstract: SIRT1 is a highly-conserved NAD(+)-dependent protein deacetylase that plays essential roles in the regulation of energy metabolism, genomic stability, and stress response. Although the functions of SIRT1 in many organs have been extensively studied in ... ...

    Abstract SIRT1 is a highly-conserved NAD(+)-dependent protein deacetylase that plays essential roles in the regulation of energy metabolism, genomic stability, and stress response. Although the functions of SIRT1 in many organs have been extensively studied in tissue-specific knockout mouse models, the systemic role of SIRT1 is still largely unknown as a result of severe developmental defects that result from whole-body knockout in mice. Here, we investigated the systemic functions of SIRT1 in metabolic homeostasis by utilizing a whole-body SIRT1 heterozygous mouse model. These mice are phenotypically normal under standard feeding conditions. However, when chronically challenged with a 40% fat diet, they become obese and insulin resistant, display increased serum cytokine levels, and develop hepatomegaly. Hepatic metabolomic analyses revealed that SIRT1 heterozygous mice have elevated gluconeogenesis and oxidative stress. Surprisingly, they are depleted of glycerolipid metabolites and free fatty acids, yet accumulate lysolipids. Moreover, high-fat feeding induces elevation of serum testosterone levels and enlargement of seminal vesicles in SIRT1 heterozygous males. Microarray analysis of liver mRNA indicates that they have altered expression of genes involved in steroid metabolism and glycerolipid metabolism. Taken together, our findings indicate that SIRT1 plays a vital role in the regulation of systemic energy and steroid hormone homeostasis.
    MeSH term(s) Animals ; Cytokines/blood ; Diet, High-Fat/adverse effects ; Energy Metabolism ; Fatty Acids, Nonesterified/metabolism ; Gene Expression Profiling ; Gluconeogenesis ; Glycolipids/metabolism ; Heterozygote ; Homeostasis ; Hyperandrogenism/etiology ; Hyperandrogenism/genetics ; Hyperandrogenism/metabolism ; Insulin Resistance ; Liver/metabolism ; Male ; Metabolome ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Obesity/etiology ; Obesity/genetics ; Obesity/metabolism ; Sirtuin 1/deficiency ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Steroids/metabolism
    Chemical Substances Cytokines ; Fatty Acids, Nonesterified ; Glycolipids ; Steroids ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-)
    Language English
    Publishing date 2011-10-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.11-195172
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SIRT1 performs a balancing act on the tight-rope toward longevity.

    Purushotham, Aparna / Schug, Thaddeus T / Li, Xiaoling

    Aging

    2009  Volume 1, Issue 7, Page(s) 669–673

    Abstract: Our recent study defined a new role for SIRT1 as a regulator of hepatic lipid metabolism. In the liver a major target of this sirtuin is the PPARalpha/PGC-1alpha signaling axis. Ablation of SIRT1 in the liver results in disrupted fatty acid oxidation, ... ...

    Abstract Our recent study defined a new role for SIRT1 as a regulator of hepatic lipid metabolism. In the liver a major target of this sirtuin is the PPARalpha/PGC-1alpha signaling axis. Ablation of SIRT1 in the liver results in disrupted fatty acid oxidation, increased cellular stress, and elevations in proinflammatory cytokines. However, contrary to previous studies, we observed no changes in glucose production in the absence of SIRT1, despite impaired PGC-1alpha signaling. These findings point toward the involvement of other players in SIRT1-regulated hepatic metabolism. Here we discuss our findings, and comment on some of the controversy surrounding this protein in the current literature.
    MeSH term(s) Animals ; Cytokines/metabolism ; Fatty Acids/metabolism ; Gluconeogenesis/physiology ; Humans ; Lipid Metabolism/physiology ; Liver/metabolism ; Longevity/physiology ; Mice ; Mice, Knockout ; Oxidation-Reduction ; PPAR alpha/genetics ; PPAR alpha/metabolism ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Stress, Physiological/physiology ; Trans-Activators/metabolism ; Transcription Factors
    Chemical Substances Cytokines ; Fatty Acids ; PPAR alpha ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Ppargc1a protein, mouse ; Trans-Activators ; Transcription Factors ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-)
    Language English
    Publishing date 2009-07-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ISSN 1945-4589
    ISSN (online) 1945-4589
    DOI 10.18632/aging.100076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells.

    Purushotham, Aparna / Tian, Min / Belury, Martha A

    Molecular nutrition & food research

    2009  Volume 53, Issue 2, Page(s) 300–307

    Abstract: Hepatic gluconeogenesis is the major source of fasting hyperglycemia. Here, we investigated the role of the citrus fruit flavonoid naringenin, in the attenuation of hepatic glucose production from hepatoma (Fao) cells. We show that naringenin, but not ... ...

    Abstract Hepatic gluconeogenesis is the major source of fasting hyperglycemia. Here, we investigated the role of the citrus fruit flavonoid naringenin, in the attenuation of hepatic glucose production from hepatoma (Fao) cells. We show that naringenin, but not its glucoside naringin, suppresses hepatic glucose production. Furthermore, unlike insulin-mediated suppression of hepatic glucose production, incubation of hepatocytes with the phosphatidylinositol 3-kinase (PI3-kinase) inhibitor Ly294002 had no effect on the ability of naringenin to suppress hepatic glucose production. Further, naringenin did not increase phosphorylation of Akt at Ser473 or, Thr308, indicating this down-stream target of PI3-kinase is also not a player in naringenin-mediated suppression of hepatic glucose production. Importantly, like the dimethylbiguanide, metformin, naringenin significantly decreased cellular ATP levels without increasing cell cytotoxicity. Together, these results suggest that the aglycone, naringenin, has a role in the attenuation of hyperglycemia and may exert this effect in a manner similar to the drug, metformin.
    MeSH term(s) Animals ; Dose-Response Relationship, Drug ; Flavanones/pharmacology ; Glucose/metabolism ; Glucose-6-Phosphatase/genetics ; Hypoglycemic Agents/pharmacology ; Liver/metabolism ; Liver Neoplasms, Experimental/metabolism ; Metformin/pharmacology ; Phosphatidylinositol 3-Kinases/physiology ; Phosphoenolpyruvate Carboxykinase (GTP)/genetics ; Rats ; Signal Transduction
    Chemical Substances Flavanones ; Hypoglycemic Agents ; Metformin (9100L32L2N) ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; Glucose-6-Phosphatase (EC 3.1.3.9) ; Phosphoenolpyruvate Carboxykinase (GTP) (EC 4.1.1.32) ; naringenin (HN5425SBF2) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2009-02
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2160372-8
    ISSN 1613-4133 ; 1613-4125
    ISSN (online) 1613-4133
    ISSN 1613-4125
    DOI 10.1002/mnfr.200700514
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells

    Purushotham, Aparna / Tian, Min / Belury, Martha.A

    Molecular nutrition & food research. 2009 Feb., v. 53, no. 2

    2009  

    Abstract: Hepatic gluconeogenesis is the major source of fasting hyperglycemia. Here, we investigated the role of the citrus fruit flavonoid naringenin, in the attenuation of hepatic glucose production from hepatoma (Fao) cells. We show that naringenin, but not ... ...

    Abstract Hepatic gluconeogenesis is the major source of fasting hyperglycemia. Here, we investigated the role of the citrus fruit flavonoid naringenin, in the attenuation of hepatic glucose production from hepatoma (Fao) cells. We show that naringenin, but not its glucoside naringin, suppresses hepatic glucose production. Furthermore, unlike insulin-mediated suppression of hepatic glucose production, incubation of hepatocytes with the phosphatidylinositol 3-kinase (PI3-kinase) inhibitor Ly294002 had no effect on the ability of naringenin to suppress hepatic glucose production. Further, naringenin did not increase phosphorylation of Akt at Ser473 or, Thr308, indicating this down-stream target of PI3-kinase is also not a player in naringenin-mediated suppression of hepatic glucose production. Importantly, like the dimethylbiguanide, metformin, naringenin significantly decreased cellular ATP levels without increasing cell cytotoxicity. Together, these results suggest that the aglycone, naringenin, has a role in the attenuation of hyperglycemia and may exert this effect in a manner similar to the drug, metformin.
    Keywords adenosine triphosphate ; citrus fruits ; cytotoxicity ; gluconeogenesis ; glucose ; hepatoma ; hyperglycemia ; metformin ; naringenin ; naringin ; phosphatidylinositol 3-kinase ; phosphorylation
    Language English
    Dates of publication 2009-02
    Size p. 300-307.
    Publishing place Wiley-VCH Verlag
    Document type Article
    ZDB-ID 2160372-8
    ISSN 1613-4133 ; 1613-4125
    ISSN (online) 1613-4133
    ISSN 1613-4125
    DOI 10.1002/mnfr.200700514
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice.

    Wendel, Angela A / Purushotham, Aparna / Liu, Li-Fen / Belury, Martha A

    Lipids

    2009  Volume 44, Issue 11, Page(s) 975–982

    Abstract: Conjugated linoleic acid (CLA) reduces body weight and adipose mass in a variety of species. The mechanisms by which CLA depletes adipose mass are unclear, but two independent microarray analyses indicate that in white adipose tissue (WAT), uncoupling ... ...

    Abstract Conjugated linoleic acid (CLA) reduces body weight and adipose mass in a variety of species. The mechanisms by which CLA depletes adipose mass are unclear, but two independent microarray analyses indicate that in white adipose tissue (WAT), uncoupling protein 1 (UCP1) was among genes most changed by CLA. The objective of this study was to determine whether CLA induces ectopic expression of UCP1 in WAT, which may contribute to increased energy expenditure and weight loss. Six-week old, male ob/ob mice were fed either a control diet (CON) or a diet supplemented with 1.5% mixed isomer CLA (CLA) for 4 weeks. A third group of mice (LEPTIN) was fed the control diet and received daily injections of recombinant leptin as a positive control for adipose depletion in ob/ob mice. CLA did not alter several mRNA markers of lipid oxidation in epididymal white adipose tissue (eWAT) , but significantly increased carnitine palmitoyltransferase-1b (CPT1b) and PPAR gamma coactivator-1alpha (PGC1alpha) expression. Notably, CLA increased both mRNA and protein expression of uncoupling protein-1 (UCP1). beta3-adrenoceptor mRNA and phosphorylated-p38 mitogen activated protein kinase (MAPK) protein levels were not affected by CLA, but were upregulated by LEPTIN. These data suggest the increased CPT1b, PGC1alpha, and UCP1, in WAT of CLA-fed mice may contribute to the depletion of adipose, and CLA does not appear to increase UCP1 through beta3-adrenergic signaling. Future studies will focus on understanding how CLA increases mitochondrial oxidation and energy dissipation in white adipose tissue.
    MeSH term(s) Adipose Tissue, White/drug effects ; Adipose Tissue, White/metabolism ; Animals ; Body Weight ; Carnitine O-Palmitoyltransferase/genetics ; Carnitine O-Palmitoyltransferase/metabolism ; Energy Metabolism ; Ion Channels/genetics ; Ion Channels/metabolism ; Leptin/metabolism ; Linoleic Acids, Conjugated/pharmacology ; Male ; Mice ; Mice, Transgenic ; Mitochondrial Proteins/genetics ; Mitochondrial Proteins/metabolism ; Obesity/genetics ; Obesity/metabolism ; RNA, Messenger/metabolism ; Uncoupling Protein 1
    Chemical Substances Ion Channels ; Leptin ; Linoleic Acids, Conjugated ; Mitochondrial Proteins ; RNA, Messenger ; UCP1 protein, human ; Ucp1 protein, mouse ; Uncoupling Protein 1 ; Carnitine O-Palmitoyltransferase (EC 2.3.1.21)
    Language English
    Publishing date 2009-09-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 241539-2
    ISSN 1558-9307 ; 0024-4201
    ISSN (online) 1558-9307
    ISSN 0024-4201
    DOI 10.1007/s11745-009-3348-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice.

    Wendel, Angela A / Purushotham, Aparna / Liu, Li-Fen / Belury, Martha A

    Journal of lipid research

    2007  Volume 49, Issue 1, Page(s) 98–106

    Abstract: Conjugated linoleic acid (CLA) induces insulin resistance preceded by rapid depletion of the adipokines leptin and adiponectin, increased inflammation, and hepatic steatosis in mice. To determine the role of leptin in CLA-mediated insulin resistance and ... ...

    Abstract Conjugated linoleic acid (CLA) induces insulin resistance preceded by rapid depletion of the adipokines leptin and adiponectin, increased inflammation, and hepatic steatosis in mice. To determine the role of leptin in CLA-mediated insulin resistance and hepatic steatosis, recombinant leptin was coadministered with dietary CLA in ob/ob mice to control leptin levels and to, in effect, negate the leptin depletion effect of CLA. In a 2 x 2 factorial design, 6 week old male ob/ob mice were fed either a control diet or a diet supplemented with CLA and received daily intraperitoneal injections of either leptin or vehicle for 4 weeks. In the absence of leptin, CLA significantly depleted adiponectin and induced insulin resistance, but it did not increase hepatic triglyceride concentrations or adipose inflammation, marked by interleukin-6 and tumor necrosis factor-alpha mRNA expression. Insulin resistance, however, was accompanied by increased macrophage infiltration (F4/80 mRNA) in adipose tissue. In the presence of leptin, CLA depleted adiponectin but did not induce insulin resistance or macrophage infiltration. Despite this, CLA induced hepatic steatosis. In summary, CLA worsened insulin resistance without evidence of inflammation or hepatic steatosis in mice after 4 weeks. In the presence of leptin, CLA failed to worsen insulin resistance but induced hepatic steatosis in ob/ob mice.
    MeSH term(s) Adiponectin/blood ; Animals ; Body Weight ; Dietary Fats, Unsaturated/administration & dosage ; Fatty Liver/chemically induced ; Fatty Liver/metabolism ; Glucose/analysis ; Insulin/blood ; Insulin Resistance ; Interleukin-6/blood ; Leptin/administration & dosage ; Leptin/metabolism ; Linoleic Acids, Conjugated/administration & dosage ; Lipid Metabolism ; Macrophages/drug effects ; Male ; Mice ; Mice, Mutant Strains ; Mice, Obese ; Obesity/metabolism ; Recombinant Proteins/administration & dosage ; Tumor Necrosis Factor-alpha/blood
    Chemical Substances Adiponectin ; Dietary Fats, Unsaturated ; Insulin ; Interleukin-6 ; Leptin ; Linoleic Acids, Conjugated ; Recombinant Proteins ; Tumor Necrosis Factor-alpha ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2007-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.M700195-JLR200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

    Liu, Li-Fen / Purushotham, Aparna / Wendel, Angela A / Belury, Martha A

    American journal of physiology. Gastrointestinal and liver physiology

    2007  Volume 292, Issue 6, Page(s) G1671–82

    Abstract: Dysfunctional cross talk between adipose tissue and liver tissue results in metabolic and inflammatory disorders. As an insulin sensitizer, rosiglitazone (Rosi) improves insulin resistance yet causes increased adipose mass and weight gain in mice and ... ...

    Abstract Dysfunctional cross talk between adipose tissue and liver tissue results in metabolic and inflammatory disorders. As an insulin sensitizer, rosiglitazone (Rosi) improves insulin resistance yet causes increased adipose mass and weight gain in mice and humans. Conjugated linoleic acid (CLA) reduces adipose mass and body weight gain but induces hepatic steatosis in mice. We examined the combined effects of Rosi and CLA on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed male C57Bl/6 mice. CLA alone suppressed weight gain and adipose mass but caused hepatic steatosis. Addition of Rosi attenuated CLA-induced insulin resistance and dysregulation of adipocytokines. In adipose, CLA significantly suppressed lipoprotein lipase and fatty acid translocase (FAT/CD36) mRNA, suggesting inhibition of fatty acid uptake into adipose; addition of Rosi completely rescued this effect. In addition, CLA alone increased markers of macrophage infiltration, F4/80, and CD68 mRNA levels, without inducing TNF-alpha in epididymal adipose tissue. The ratio of Bax to Bcl2, a marker of apoptosis, was significantly increased in adipose of the CLA-alone group and was partially prevented by treatment of Rosi. Immunohistochemistry of F4/80 demonstrates a proinflammatory response induced by CLA in epididymal adipose. In the liver, CLA alone induced microsteatotic liver but surprisingly increased the rate of very-low-density lipoprotein-triglyceride production without inducing inflammatory mediator-TNF-alpha and markers of macrophage infiltration. These changes were accompanied by significantly increased mRNA levels of stearoyl-CoA desaturase, FAT/CD36, and fatty acid synthase. The combined administration of CLA and Rosi reduced hepatic liver triglyceride content as well as lipogenic gene expression compared with CLA alone. In summary, dietary CLA prevented weight gain in Rosi-treated mice without attenuating the beneficial effects of Rosi on insulin sensitivity. Rosi ameliorated CLA-induced lipodystrophic disorders that occurred in parallel with rescued expression of adipocytokine and adipocytes-abundant genes.
    MeSH term(s) Adipocytes/drug effects ; Adipocytes/metabolism ; Adiponectin/blood ; Adipose Tissue/drug effects ; Adipose Tissue/metabolism ; Adipose Tissue/pathology ; Adipose Tissue/physiopathology ; Adiposity/drug effects ; Animals ; Apoptosis/drug effects ; Body Weight/drug effects ; Dietary Fats ; Disease Models, Animal ; Drug Therapy, Combination ; Fatty Liver/chemically induced ; Fatty Liver/metabolism ; Fatty Liver/physiopathology ; Fatty Liver/prevention & control ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/pharmacology ; Insulin Resistance ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Leptin/blood ; Linoleic Acids, Conjugated/adverse effects ; Linoleic Acids, Conjugated/pharmacology ; Lipid Metabolism/drug effects ; Lipid Metabolism/genetics ; Lipoproteins, VLDL/metabolism ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Liver/physiopathology ; Macrophages/drug effects ; Macrophages/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Obesity/drug therapy ; Obesity/etiology ; Obesity/metabolism ; Obesity/physiopathology ; RNA, Messenger/metabolism ; Thiazolidinediones/adverse effects ; Thiazolidinediones/pharmacology ; Time Factors ; Triglycerides/metabolism
    Chemical Substances Adiponectin ; Adipoq protein, mouse ; Dietary Fats ; Hypoglycemic Agents ; Intracellular Signaling Peptides and Proteins ; Leptin ; Linoleic Acids, Conjugated ; Lipoproteins, VLDL ; RNA, Messenger ; Thiazolidinediones ; Triglycerides ; very low density lipoprotein triglyceride ; rosiglitazone (05V02F2KDG)
    Language English
    Publishing date 2007-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603840-2
    ISSN 1522-1547 ; 0193-1857
    ISSN (online) 1522-1547
    ISSN 0193-1857
    DOI 10.1152/ajpgi.00523.2006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.

    Purushotham, Aparna / Xu, Qing / Lu, Jing / Foley, Julie F / Yan, Xingjian / Kim, Dong-Hyun / Kemper, Jongsook Kim / Li, Xiaoling

    Molecular and cellular biology

    2012  Volume 32, Issue 7, Page(s) 1226–1236

    Abstract: SIRT1, a highly conserved NAD(+)-dependent protein deacetylase, is a key metabolic sensor that directly links nutrient signals to animal metabolic homeostasis. Although SIRT1 has been implicated in a number of hepatic metabolic processes, the mechanisms ... ...

    Abstract SIRT1, a highly conserved NAD(+)-dependent protein deacetylase, is a key metabolic sensor that directly links nutrient signals to animal metabolic homeostasis. Although SIRT1 has been implicated in a number of hepatic metabolic processes, the mechanisms by which hepatic SIRT1 modulates bile acid metabolism are still not well understood. Here we report that deletion of hepatic SIRT1 reduces the expression of farnesoid X receptor (FXR), a nuclear receptor that regulates bile acid homeostasis. We provide evidence that SIRT1 regulates the expression of FXR through hepatocyte nuclear factor 1α (HNF1α). SIRT1 deficiency in hepatocytes leads to decreased binding of HNF1α to the FXR promoter. Furthermore, we show that hepatocyte-specific deletion of SIRT1 leads to derangements in bile acid metabolism, predisposing the mice to development of cholesterol gallstones on a lithogenic diet. Taken together, our findings indicate that SIRT1 plays a vital role in the regulation of hepatic bile acid homeostasis through the HNF1α/FXR signaling pathway.
    MeSH term(s) Animals ; Cholesterol/metabolism ; Gallstones/metabolism ; Gene Deletion ; Gene Expression Regulation ; HEK293 Cells ; Hepatocyte Nuclear Factor 1-alpha/metabolism ; Humans ; Lipid Metabolism ; Liver/metabolism ; Mice ; Mice, Inbred C57BL ; Receptors, Cytoplasmic and Nuclear/genetics ; Receptors, Cytoplasmic and Nuclear/metabolism ; Signal Transduction ; Sirtuin 1/genetics ; Sirtuin 1/metabolism
    Chemical Substances Hepatocyte Nuclear Factor 1-alpha ; Receptors, Cytoplasmic and Nuclear ; farnesoid X-activated receptor (0C5V0MRU6P) ; Cholesterol (97C5T2UQ7J) ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-)
    Language English
    Publishing date 2012-01-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 779397-2
    ISSN 1098-5549 ; 0270-7306
    ISSN (online) 1098-5549
    ISSN 0270-7306
    DOI 10.1128/MCB.05988-11
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice.

    Purushotham, Aparna / Wendel, Angela A / Liu, Li-Fen / Belury, Martha A

    Journal of lipid research

    2006  Volume 48, Issue 2, Page(s) 444–452

    Abstract: Conjugated linoleic acid (CLA) causes insulin resistance and hepatic steatosis in conjunction with depletion of adipokines in some rodent models. Our objective was to determine whether the maintenance of adipokines, mainly leptin and adiponectin, by ... ...

    Abstract Conjugated linoleic acid (CLA) causes insulin resistance and hepatic steatosis in conjunction with depletion of adipokines in some rodent models. Our objective was to determine whether the maintenance of adipokines, mainly leptin and adiponectin, by either removing CLA from diets or using an adiponectin enhancer, rosiglitazone (ROSI), could attenuate CLA-induced insulin resistance. Male C57BL/6 mice were consecutively fed two experimental diets containing 1.5% CLA mixed isomer for 4 weeks followed by a diet without CLA for 4 weeks. CLA significantly depleted adiponectin but not leptin and was accompanied by hepatic steatosis and insulin resistance. These effects were attenuated after switching mice to the diet without CLA along with restoration of adiponectin. To further elucidate the role of adiponectin in CLA-mediated insulin resistance, ROSI was used in a subsequent study in male ob/ob mice fed either control (CON) or CLA diet. ROSI maintained significantly higher adiponectin levels in CON- and CLA-fed mice and prevented the depletion of epididymal adipose tissue and the development of insulin resistance. In conclusion, we show that insulin resistance induced by CLA may be related more to adiponectin depletion than to leptin and that maintaining adiponectin levels alone either by removing CLA or using ROSI can attenuate these effects.
    MeSH term(s) Adiponectin/metabolism ; Animals ; Body Weight ; Dietary Fats/pharmacology ; Disease Models, Animal ; Insulin Resistance/physiology ; Linoleic Acids, Conjugated/pharmacology ; Liver/drug effects ; Male ; Mice ; Mice, Inbred C57BL ; Organ Size
    Chemical Substances Adiponectin ; Dietary Fats ; Linoleic Acids, Conjugated
    Language English
    Publishing date 2006-10-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.M600393-JLR200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

    Purushotham, Aparna / Schug, Thaddeus T / Xu, Qing / Surapureddi, Sailesh / Guo, Xiumei / Li, Xiaoling

    Cell metabolism

    2008  Volume 9, Issue 4, Page(s) 327–338

    Abstract: Hepatic metabolic derangements are key components in the development of fatty liver, insulin resistance, and atherosclerosis. SIRT1, a NAD+-dependent protein deacetylase, is an important regulator of energy homeostasis in response to nutrient ... ...

    Abstract Hepatic metabolic derangements are key components in the development of fatty liver, insulin resistance, and atherosclerosis. SIRT1, a NAD+-dependent protein deacetylase, is an important regulator of energy homeostasis in response to nutrient availability. Here we demonstrate that hepatic SIRT1 regulates lipid homeostasis by positively regulating peroxisome proliferators-activated receptor alpha (PPARalpha), a nuclear receptor that mediates the adaptive response to fasting and starvation. Hepatocyte-specific deletion of SIRT1 impairs PPARalpha signaling and decreases fatty acid beta-oxidation, whereas overexpression of SIRT1 induces the expression of PPARalpha targets. SIRT1 interacts with PPARalpha and is required to activate PPARalpha coactivator PGC-1alpha. When challenged with a high-fat diet, liver-specific SIRT1 knockout mice develop hepatic steatosis, hepatic inflammation, and endoplasmic reticulum stress. Taken together, our data indicate that SIRT1 plays a vital role in the regulation of hepatic lipid homeostasis and that pharmacological activation of SIRT1 may be important for the prevention of obesity-associated metabolic diseases.
    MeSH term(s) Animals ; Dietary Fats/administration & dosage ; Dietary Fats/pharmacology ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/pathology ; Fatty Acids/metabolism ; Fatty Liver/complications ; Fatty Liver/enzymology ; Feeding Behavior/drug effects ; Gene Deletion ; Hepatocytes/drug effects ; Hepatocytes/enzymology ; Homeostasis/drug effects ; Inflammation/complications ; Inflammation/enzymology ; Ligands ; Lipid Metabolism/drug effects ; Mice ; Organ Specificity/drug effects ; Oxidation-Reduction/drug effects ; PPAR alpha/metabolism ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Protein Binding/drug effects ; Signal Transduction/drug effects ; Sirtuin 1 ; Sirtuins/genetics ; Sirtuins/metabolism ; Trans-Activators/metabolism ; Transcription Factors ; Transcriptional Activation/drug effects
    Chemical Substances Dietary Fats ; Fatty Acids ; Ligands ; PPAR alpha ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Ppargc1a protein, mouse ; Trans-Activators ; Transcription Factors ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-) ; Sirtuins (EC 3.5.1.-)
    Language English
    Publishing date 2008-03-04
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2009.02.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top